Systemic Levels of Anti-VEGF: What Available Data Reveal

Show Description +

Robert L. Avery, MD, discusses the recent finding from CATT, IVAN on systemic concentrations of bevacizumab and ranibizumab after injection, the EPAR report in regard to the systemic safety of aflibercept, and his own study on serum levels of anti-VEGF drug levels (bevacizumab, ranibizumab, and aflibercept) and free VEGF in human plasma.

Posted: 1/16/2014

Systemic Levels of Anti-VEGF: What Available Data Reveal

Robert L. Avery, MD, discusses the recent finding from CATT, IVAN on systemic concentrations of bevacizumab and ranibizumab after injection, the EPAR report in regard to the systemic safety of aflibercept, and his own study on serum levels of anti-VEGF drug levels (bevacizumab, ranibizumab, and aflibercept) and free VEGF in human plasma.

Posted: 1/16/2014

Please log in to leave a comment.

Comments

majid kheirkhahr

12 years ago

amazing.

More in Retina

Retinal Arterial Microaneurysms Associated with Preretinal Macular Hemorrhage

Saksonov Stanislav; Teslenko Olexandr; and Dmytrulina Nikolietta

Encelto Implant Surgery

Rupan Trikha, MD

High-Tech Solutions for Low Vison

Sharon Fekrat, MD, FACS